Frederick Tay
Frederick is with the firm’s corporate practice, specialising in mergers and acquisitions and corporate transactions. He has more than 10 years of experience in the healthcare and consumer healthcare industry.
In the healthcare and life sciences industry, Frederick has advised and implemented both operational and transactional solutions for companies which include advising on supply contracts for active pharmaceutical ingredients in the manufacturing process, pricing and supply of medicines contracts with both public and private healthcare practices, advising on cross-border transactions globally, and advising on digital projects.
Contact Information:
All Posts:
Read Here
Advertise
Sign Up
Commentary
What matters for Singapore’s AI future is consistency, not brilliance
The AI pilot worked. Now comes the real test
Are Singapore startups’ employee incentive plans still competitive?
Singapore’s small exporters need credit that matches their payment cycle
The hidden realities of succession for next-gen heirs
In Asia, fintech leaders must compete on credibility
F1 on a gravel road: Why AI is still stuck in first gear
Why AI blocklists give Singapore firms a false sense of security
When scale arrives before proof: Singapore’s capital allocation question in Southeast Asia